44860 Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 

For program specific questions, 

persons are encouraged to go to 

jkhirsh@northwestern.edu. To register 

for the October 14–16 meeting, 

interested persons should go to http:// 

www.orwhmeetings.com/ 

movingintothefuture/northwestern. 

Dated: August 24, 2009. 

Vivian W. Pinn, 

Associate Director for Research on Women’s 

Health and Director, Office of Research on 

Women’s Health, NIH, National Institutes of 

Health. 

[FR Doc. E9–20883 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Cancer Institute Clinical Trials 

and Translational Research Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials and Translational 

Research Advisory Committee. 

Date: November 4, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: Update on the progress of the 

implementation of the Clinical Trials 

Working Group and the Translational 

Research Working Group reports. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Sheila A. Prindiville, MD, 

MPH, Director, Coordinating Center for 

Clinical Trials, Office of the Director, 

National Cancer Institute, National Institutes 

of Health, 6120 Executive Blvd., 3rd Floor 

Suite, Bethesda, MD 20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20877 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group 

Urologic and Kidney Development and 

Genitourinary Diseases Study Section. 

Date: September 21, 2009. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Amalfi Hotel Chicago, 20 West 

Kinzie Street, Chicago, IL 60654. 

Contact Person: Ryan G. Morris, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group Instrumentation and Systems 

Development Study Section. 

Date: September 22, 2009. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Dulles Airport, 

2200 Centreville Road, Herndon, VA 20170. 

Contact Person: Raymond Jacobson, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, MSC 7849, 

Bethesda, MD 20892, 301–435–0483, 

jacobsonrh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Cancer 

Prevention. 

Date: September 22, 2009. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lawrence Ka-Yun Ng, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutues of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1719, ngkl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Radiation 

SEP. 

Date: September 22, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Sally A. Mulhern, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

5877, mulherns@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflicts: Social Science and Population 

Studies. 

Date: September 23–24, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Suzanne Ryan, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

Bethesda, MD 20892, (301) 435–1712, 

ryansj@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group Integrative 

Physiology of Obesity and Diabetes Study 

Section. 

Date: September 24–25, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel, 701 North 

Michigan Avenue, Chicago, IL 60611. 

Contact Person: Reed A. Graves, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6166, 

MSC 7892, Bethesda, MD 20892, (301) 402– 

6297, gravesr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Research on 

Ethical Issues in Human Studies. 


cprice-sewell on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices 44861 

Date: September 24, 2009. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Ellen K. Schwartz, EDD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, 301–435– 

0681, schwarte@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group Biomaterials and Biointerfaces Study 

Section. 

Date: September 30–October 1, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Steven J. Zullo, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5146, 

MSC 7849, Bethesda, MD 20892, 301–435– 

2810, zullost@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group Nanotechnology Study Section. 

Date: September 30–October 1, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin Annapolis Hotel, 100 

Westgate Circle, Annapolis, MD 21401. 

Contact Person: Joseph D. Mosca, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5158, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2344, moscajos@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20876 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, National 

Institute of Neurological Disorders and 

Stroke. The meeting will be closed to 

the public as indicated below in 

accordance with the provisions set forth 

in section 552b(c)(6), Title 5 U.S.C., as 

amended for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Neurological 

Disorders and Stroke, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of 

Neurological Disorders and Stroke. 

Date: October 4–6, 2009. 

Time: 7 p.m. to 12:30 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Alan P. Koretsky, PhD, 

Scientific Director, Division of Intramural 

Research, National Institute of Neurological 

Disorders & Stroke, NIH, 35 Convent Drive, 

Room 6A 908, Bethesda, MD 20892, 301– 

435–2232, koretskya@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: August 24, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–20874 Filed 8–28–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Services Subcommittee of the 

Interagency Autism Coordinating 

Committee (IACC). 

The purpose of the Services 

Subcommittee is to review the current 

state of services and supports for 

individuals with Autism Spectrum 

Disorder (ASD) and their families in 

order to improve these services. The 

meeting will be open to the public with 

attendance limited to space available. 

The meeting will also be open to the 

public through a conference call phone 

number and a Web presentation tool on 

the Internet. Individuals who participate 

in person or by using electronic services 

and who need special assistance, such 

as captioning of the conference call or 

other reasonable accommodations, 

should submit a request to the Contact 

Person at least 7 days prior to the 

meeting. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of meeting: Services Subcommittee. 

Date: September 15, 2009. 

Time: 1 p.m. to 4 p.m. Eastern Time. 

Agenda: Discussion of the IACC Services 

Town Hall Meeting that took place on July 

24, 2009 in St. Charles, IL, and a presentation 

by IACC Services Subcommittee member Dr. 

Gail Houle and Dr. Sam Odom about 

programs for children with autism supported 

by the Department of Education. 

Place: 

In Person: National Institutes of Health, 

Main Campus Building 1, Wilson Hall, 3rd 

Floor, 1 Center Drive, Bethesda, MD 20892. 

Webinar: https://www2.gotomeeting.com/ 

register/724090747. To Access the 

Conference Call: Dial: 888–455–2920. Access 

code: 5697907. 

Contact Person: Ms. Lina Perez, Office of 

Autism Research Coordination, Office of the 

Director, National Institute of Mental Health, 

NIH, 6001 Executive Boulevard, NSC, Room 

8200, Bethesda, MD 20892–9669. 301–443– 

6040. IACCPublicInquiries@mail.nih.gov. 

Please Note: Members of the public who 

participate using the conference call phone 

number will be able to listen to the meeting 

but will not be heard. For those who use the 

Web presentation tool to view the 

presentation, please call GoToWebinar at 

(800) 263–6317 to report any technical 

difficulties. 

To access the Web presentation tool 

on the Internet the following computer 

capabilities are required: 

(A) Internet Explorer 5.0 or later, 

Netscape Navigator 6.0 or later or 

Mozilla Firefox 1.0 or later; 

(B) Windows® 2000, XP Home, XP 

Pro, 2003 Server or Vista; 

(C) Stable 56k, cable modem, ISDN, 

DSL or better Internet connection; 

(D) Minimum of Pentium 400 with 

256 MB of RAM (Recommended); 

(E) Java Virtual Machine enabled 

(Recommended). 

NIH has instituted stringent security 

procedures for entrance onto the NIH 

campus. All visitors must enter through 

the NIH Gateway Center. This center 

combines visitor parking, noncommercial vehicle inspection and 

visitor ID processing, all in one location. 

The NIH will process all visitors in 

vehicles or as pedestrians. You will be 

asked to submit to a vehicle or personal 

inspection and will be asked to state the 

purpose of your visit. Visitors over 15 

years of age must provide a form of 

government-issued ID such as a driver’s 


cprice-sewell on DSK2BSOYB1PROD with NOTICES